In addition, a scoring system called Immunoscore, which summarizes the densities of CD3+ and CD8+ T‐cell effectors within the tumor and its invasive margins, has been shown to be useful in predicting the clinical outcome of patients with CRC.11 Here, CD8A is linked to neoplasm.